Gennex Laboratories Ltd

NSE: GENNEX · BSE: 531739 · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹9.99
Market cap: ₹242.7 Cr
Revenue (annual): ₹172.7 Cr
Net profit (annual): ₹20.98 Cr
P/E (TTM): 10.3×Sector 47.4×
Promoter holding: 23.63%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 5 Financial Results 3 Board Meeting Date 3 Other Announcement 2 Board Meeting Outcome 2 Share Pledge 1 Price Movement Clarification 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

20 Jul 2026 13:58 IST BSE

Other Announcement

Gennex Laboratories Other Announcement

Gennex Laboratories Ltd filed its quarterly shareholding pattern. The company has applied for trading approval for 1.55 crore shares issued via warrant conversion.

Read the filing ↗

30 May 2026 12:12 IST BSE

Other Announcement

Gennex Laboratories Other Announcement

Gennex Laboratories submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The report confirms adherence to statutory regulations and outlines historical compliance actions taken.

Read the filing ↗